Giant axonal neuropathy: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Giant Axonal Neuropathy''' ('''GAN''') is a rare genetic disorder that affects both the peripheral and central nervous systems. The disorder is characterized by abnormally large and dysfunctional axons, leading to a breakdown in communication between the brain and muscles.
{{SI}}
 
{{Infobox medical condition
== Symptoms ==
| name            = Giant axonal neuropathy
The symptoms of GAN typically begin in early childhood and progress slowly as the disorder affects the nervous system. These symptoms may include:
| image          = [[File:autorecessive.svg|200px]]
 
| caption        = Giant axonal neuropathy is inherited in an [[autosomal recessive]] pattern.
* Difficulty walking
| synonyms        = GAN
* Loss of muscle control
| pronounce      =
* Decreased sensation in the extremities
| specialty      = [[Neurology]], [[Genetics]]
* Seizures
| symptoms        = [[Peripheral neuropathy]], [[ataxia]], [[dysarthria]], [[seizures]], [[intellectual disability]]
* Intellectual disability
| onset          = Childhood
 
| duration        = Progressive
== Causes ==
| causes          = Mutations in the [[GAN (gene)|GAN gene]]
GAN is caused by mutations in the GAN gene. This gene provides instructions for making a protein called gigaxonin, which is involved in the maintenance and function of nerve cells. Mutations in the GAN gene disrupt the normal function of gigaxonin, leading to the characteristic features of GAN.
| risks          =
 
| diagnosis      = [[Genetic testing]], [[nerve biopsy]]
| differential    = [[Charcot-Marie-Tooth disease]], [[Friedreich's ataxia]]
| treatment      = Supportive care, [[physical therapy]], [[occupational therapy]]
| medication      =
| prognosis      = Variable, often progressive
| frequency      = Rare
| deaths          =
}}
{{DISPLAYTITLE:Giant Axonal Neuropathy}}
== Introduction ==
'''Giant Axonal Neuropathy''' (GAN) is a rare [[genetic disorder]] that affects the [[nervous system]]. It is characterized by the abnormal growth of [[axons]], which are the long, threadlike extensions of [[neurons]] that transmit [[nerve impulses]]. This condition is inherited in an [[autosomal recessive]] pattern, meaning that both copies of the gene in each cell have mutations.
== Pathophysiology ==
GAN is caused by mutations in the [[GAN gene]], which provides instructions for making a protein called gigaxonin. This protein is involved in the breakdown of intermediate filaments, which are part of the cell's [[cytoskeleton]]. In individuals with GAN, the abnormal gigaxonin leads to the accumulation of intermediate filaments in the axons, causing them to swell and become dysfunctional.
== Clinical Features ==
The symptoms of Giant Axonal Neuropathy typically begin in early childhood. Affected individuals often experience:
* [[Peripheral neuropathy]], leading to muscle weakness and loss of sensation in the arms and legs.
* [[Ataxia]], or lack of coordination.
* [[Dysarthria]], or difficulty speaking.
* [[Optic atrophy]], which can lead to vision problems.
* [[Curly hair]], which is a distinctive feature in many patients.
== Diagnosis ==
== Diagnosis ==
Diagnosis of GAN is based on clinical examination, genetic testing, and nerve biopsy. The presence of abnormally large axons in a nerve biopsy is a key diagnostic feature of GAN.
Diagnosis of GAN is based on clinical evaluation, family history, and genetic testing. [[Nerve biopsy]] may reveal the characteristic giant axons filled with disorganized neurofilaments. Genetic testing can confirm mutations in the GAN gene.
 
== Management ==
== Treatment ==
There is currently no cure for Giant Axonal Neuropathy. Management focuses on symptomatic treatment and supportive care, including:
There is currently no cure for GAN. Treatment is symptomatic and supportive, and may include physical therapy, occupational therapy, and medications to manage seizures and other symptoms.
* [[Physical therapy]] to maintain mobility and muscle strength.
 
* [[Occupational therapy]] to assist with daily activities.
* [[Speech therapy]] for communication difficulties.
* [[Orthopedic devices]] to support weakened limbs.
== Prognosis ==
== Prognosis ==
The prognosis for individuals with GAN varies. The disorder is progressive, and most individuals with GAN become wheelchair-bound by their teens or early adulthood. Life expectancy is also reduced, with most individuals with GAN not surviving past their 30s.
The progression of GAN varies among individuals, but it is generally a progressive disorder. Most affected individuals experience a decline in motor and sensory functions over time, leading to significant disability.
 
== See also ==
== See also ==
* [[Neurogenetic disorders]]
* [[Peripheral neuropathy]]
* [[Genetic disorders]]
* [[Autosomal recessive disorder]]
* [[Neuropathy]]
* [[Genetic testing]]
 
[[Category:Genetic disorders]]
== References ==
<references />
 
[[Category:Neurological disorders]]
[[Category:Neurological disorders]]
[[Category:Genetic disorders]]
[[Category:Rare diseases]]
{{stub}}

Latest revision as of 20:21, 6 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Giant axonal neuropathy
Synonyms GAN
Pronounce
Specialty Neurology, Genetics
Symptoms Peripheral neuropathy, ataxia, dysarthria, seizures, intellectual disability
Complications N/A
Onset Childhood
Duration Progressive
Types N/A
Causes Mutations in the GAN gene
Risks
Diagnosis Genetic testing, nerve biopsy
Differential diagnosis Charcot-Marie-Tooth disease, Friedreich's ataxia
Prevention N/A
Treatment Supportive care, physical therapy, occupational therapy
Medication
Prognosis Variable, often progressive
Frequency Rare
Deaths


Introduction[edit]

Giant Axonal Neuropathy (GAN) is a rare genetic disorder that affects the nervous system. It is characterized by the abnormal growth of axons, which are the long, threadlike extensions of neurons that transmit nerve impulses. This condition is inherited in an autosomal recessive pattern, meaning that both copies of the gene in each cell have mutations.

Pathophysiology[edit]

GAN is caused by mutations in the GAN gene, which provides instructions for making a protein called gigaxonin. This protein is involved in the breakdown of intermediate filaments, which are part of the cell's cytoskeleton. In individuals with GAN, the abnormal gigaxonin leads to the accumulation of intermediate filaments in the axons, causing them to swell and become dysfunctional.

Clinical Features[edit]

The symptoms of Giant Axonal Neuropathy typically begin in early childhood. Affected individuals often experience:

Diagnosis[edit]

Diagnosis of GAN is based on clinical evaluation, family history, and genetic testing. Nerve biopsy may reveal the characteristic giant axons filled with disorganized neurofilaments. Genetic testing can confirm mutations in the GAN gene.

Management[edit]

There is currently no cure for Giant Axonal Neuropathy. Management focuses on symptomatic treatment and supportive care, including:

Prognosis[edit]

The progression of GAN varies among individuals, but it is generally a progressive disorder. Most affected individuals experience a decline in motor and sensory functions over time, leading to significant disability.

See also[edit]